Investigation of molecular design, synthesis, and biological assessment of new benzopyran derivatives

Authors

  • Mahesh Agasa Ramu Department of Pharmaceutical Chemistry, The Oxford College of Pharmacy, Bengaluru, Karnataka, India https://orcid.org/0000-0003-4073-9021
  • Somashekhar Metri Department of Pharmaceutical Chemistry, BLDEA’S SSM College of Pharmacy and Research Centre, Vijayapura 586103, Karnataka, India
  • Trupti A Hunnura Department of Pharmaceutical Chemistry, BLDEA’S SSM College of Pharmacy and Research Centre, Vijayapura 586103, Karnataka, India
  • Koushallya Patil Department of Pharmaceutical Chemistry, BLDEA’S SSM College of Pharmacy and Research Centre, Vijayapura 586103, Karnataka, India
  • Hanamant B Sannakki Department of Pharmaceutical Chemistry, BLDEA’S SSM College of Pharmacy and Research Centre, Vijayapura 586103, Karnataka, India

DOI:

https://doi.org/10.69857/joapr.v13i1.722

Keywords:

Anti-tubercular compounds, PKS13 (PDB ID: 5v3y), Molecular Docking, Benzopyran derivatives, Alamar blue susceptibility assay (MABA)

Abstract

Background: Tuberculosis (TB) remains a global health challenge, necessitating the discovery of novel anti-tubercular agents. The N-(8-hydrazinyl-3,4-dihydro-2H-1-benzopyran-6-yl)-N'-phenyl urea (HSM-II) scaffold has shown potential in developing effective drug candidates. Objective: This study aimed to design and evaluate 50 derivatives of HSM-II for their anti-tubercular activity, focusing on compounds demonstrating strong interactions with the protein PKS13 (PDB ID: 5v3y). Methods: A series of derivatives was synthesized, starting with the reaction of 8-bromo-3,4-dihydro-2H-1-benzopyran-6-amine and phenyl carbamic acid, yielding six new benzopyran derivatives. These were further treated with various aromatic halides to produce the HSM-II derivatives. Molecular docking studies were performed to identify compounds with high binding affinity to PKS13. Promising candidates (HSM-II-3, HSM-II-13, HSM-II-27, HSM-II-33, HSM-II-42, and HSM-II-49) were selected for biological evaluation. Anti-tubercular activity was assessed in vitro using the Alamar Blue Susceptibility Test (MABA) against Mycobacterium tuberculosis H37Rv and H37Ra strains. Results: Docking studies revealed high binding scores for the selected compounds, indicating strong interactions with the target protein. In vitro evaluations demonstrated significant anti-tubercular activity for the majority of synthesized derivatives. The pharmacologic profile of the compounds suggests potential as lead candidates for further optimization. Conclusion: This study presents the design, synthesis, and biological evaluation of 50 diverse derivatives of N-(8-hydrazinyl-3,4-dihydro-2H-1-benzopyran-6-yl)-N'-phenyl urea (HSM-II). Six derivatives (HSM-II-3, HSM-II-13, HSM-II-27, HSM-II-33, HSM-II-42, and HSM-II-49) demonstrated high binding affinities with PKS13 (PDB ID: 5v3y), with scores reaching -11.4 kcal/mol, and potent in vitro anti-tubercular activity, as assessed using the Alamar Blue Susceptibility Assay (MABA). Prominent derivatives exhibited MIC values significantly lower than those of standard drugs like rifampicin.

Downloads

Download data is not yet available.

References

Mahajan A, Gupta M. Hybrid ceria and chitosan supported nickel nanoparticles: A recyclable nanocatalytic system in the reduction of nitroarenes and the synthesis of benzopyran derivatives in green solvent. Appl Organomet Chem, 35, e6161 (2021) https://doi.org/10.1002/AOC.6161.

Poonacha LK, Ramesh R, Ravish A, Mohan A, Uppar PM, Metri PK, Shivananju NS, Gaonkar SL, Gopal S, Sukhorukov AY, Pandey V, Shubha PB, Basappa B. Development of Novel Indole and Coumarin Derivatives as Antibacterial Agents That Target Histidine Kinase in S. aureus. Appl Microbiol, 3, 1214–28 (2023) https://doi.org/10.3390/APPLMICROBIOL3040084.

Abdolmohammadi S, Dahi-Azar S. Sustainable synthesis of benzopyran azo dyes using CuCr2O4 NPs. J Heterocycl Chem, 58, 2181–8 (2021) https://doi.org/10.1002/JHET.4347.

Uth JF, Börgel F, Lehmkuhl K, Schepmann D, Kaiser M, Jabor VAP, Nonato MC, Krauth-Siegel RL, Schmidt TJ, Wünsch B. Synthesis and Biological Evaluation of Natural-Product-Inspired, Aminoalkyl-Substituted 1-Benzopyrans as Novel Antiplasmodial Agents. J Med Chem, 64, 6397–409 (2021) https://doi.org/10.1021/acs.jmedchem.1c00483.

Wang S, Zhu S, Tanzeng Y, Zhang Y, Li C, Ma M, Lu W. Design, Synthesis, and Evaluation of Near-Infrared Fluorescent Molecules Based on 4H-1-Benzopyran Core. Molecules 2021, Vol. 26, Page 6986, 26, 6986 (2021) https://doi.org/10.3390/molecules26226986.

Apostol TV, Chifiriuc MC, Draghici C, Socea LI, Marutescu LG, Olaru OT, Nitulescu GM, Pahontu EM, Saramet G, Barbuceanu SF. Synthesis, In Silico and In Vitro Evaluation of Antimicrobial and Toxicity Features of New 4-benzoic Acid Derivatives. Molecules, 26, (2021) https://doi.org/10.3390/molecules26165107.

Vila L, Cabedo N, Villarroel-Vicente C, García A, Bernabeu Á, Hennuyer N, Staels B, Franck X, Figadère B, Sanz MJ, Cortes D. Synthesis and biological studies of “Polycerasoidol” and “trans-δ-Tocotrienolic acid” derivatives as PPARα and/or PPARγ agonists. Bioorg Med Chem, 53, 116532 (2022) https://doi.org/10.1016/j.bmc.2021.116532.

Mukhopadhyay A, Jindal S, Maka VK, Moorthy JN. Contrasting Photochromic and Acidochromic Behaviors of Pyridyl- And Pyrimidylethynylated Mono- And Bis-Benzopyrans. ACS Omega, 6, 21113–24 (2021) https://doi.org/10.1021/acsomega.1c02948.

Du F, Zhou Q, Fu X, Shi Y, Chen Y, Fang W, Yang J, Chen G. Synthesis and biological evaluation of 2,2-dimethylbenzopyran derivatives as potent neuroprotection agents. RSC Adv, 9, 2498–508 (2019) https://doi.org/10.1039/C8RA10424G.

Josephine Leno Jenita J, Kulkarni J, Ramu Mahesh A, Banu S, Rathore SS, Leno Jenita J. Exposition of Protein Kinase Targeted Nanoplatforms: An Extensive Review. Advances in Pharmacology and Pharmacy, 10, 128–37 (2022) https://doi.org/10.13189/app.2022.100207.

Gupta S, Park SE, Mozaffari S, El-Aarag B, Parang K, Tiwari RK. Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds. Molecules, 28, 4220 (2023) https://doi.org/10.3390/molecules28104220.

Lu Y, Sun D, Xiao D, Shao Y, Su M, Zhou Y, Li J, Zhu S, Lu W. Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands. Molecules 2021, Vol. 26, Page 7241, 26, 7241 (2021) https://doi.org/10.3390/molecules26237241.

Abourehab MAS, Alqahtani AM, Almalki FA, Abdalla AN, Gouda AM. Pyrrolizine/indolizine-cinnamaldehyde Schiff bases: Design, synthesis, biological evaluation, ADME, and molecular docking study. European Journal of Medicinal Chemistry Reports, 4, 100036 (2022) https://doi.org/10.1016/j.ejmcr.2022.100036.

Reddy DS, Kongot M, Kumar A. Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity. Tuberculosis, 127, 102050 (2021) https://doi.org/10.1016/j.tube.2020.102050.

Patil SB. Medicinal significance of novel coumarin analogs: Recent studies. Results Chem, 4, 100313 (2022) https://doi.org/10.1016/j.rechem.2022.100313.

Kaur A, Sharma V, Budhiraja A, Kaur H, Gupta V, Kant R, Ishar MPS. Synthesis and Evaluation of Substituted 4,4a-Dihydro-3H,10H-pyranobenzopyran-10-one as Antimicrobial Agent. Int Sch Res Notices, 2013, 619535 (2013) https://doi.org/10.1155/2013/619535.

Kiruthiga N, Prabha T, Selvinthanuja C, Srinivasan K, Sivakumar T. Synthesis, Biological Evaluation, And Docking Study Of Novel 2-Phenyl-1- Benzopyran-4-One Derivatives - As a Potent Cyclooxygenase-2 Inhibitor. Asian Journal of Pharmaceutical and Clinical Research, 12, 304–10 (2019)

https://doi.org/10.22159/ajpcr.2019.v12i3.30466.

Srivathsa AV, Sadashivappa NM, Hegde AK, Radha S, Mahesh AR, Ammunje DN, Sen D, Theivendren P, Govindaraj S, Kunjiappan S, Pavadai P. A Review on Artificial Intelligence Approaches and Rational Approaches in Drug Discovery. Curr Pharm Des, 29, 1180–92 (2023) https://doi.org/10.2174/1381612829666230428110542.

S Sadishkumar, S Vimal Kumar, SN Mohith, R Prathiba, S Abilash, AR Mahesh. In Silico Investigation of Chemical Components of Fragaria ananassa Species as Aphrodisiac Agents for Erectile Dysfunction. Res J Pharm Technol, 17, 3315–9 (2024)

https://doi.org/10.52711/0974-360X.2024.00518

Published

2025-02-28

How to Cite

Agasa Ramu, M., Metri, S. ., A Hunnura, T., Patil, K., & B Sannakki, H. (2025). Investigation of molecular design, synthesis, and biological assessment of new benzopyran derivatives. Journal of Applied Pharmaceutical Research, 13(1), 86-94. https://doi.org/10.69857/joapr.v13i1.722

Issue

Section

Articles